Please assess the completion status of the following clinical trial:

Trial Title: Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects aged more than or equal to (\>=) 18 years and less than or equal to (\<=) 60 years at the time of Rebif introduction~* Subjects diagnosed with RMS according to the revised McDonald criteria (2010)~* Treatment naïve or subjects on other DMDs who will switch to Rebif.~* Subjects will receive 1st Rebif 44 mcg dose after signing informed consent~* Subjects willing and able to provide signed informed consent.~Exclusion Criteria:~* Have any contraindications to treatment with IFN beta-1a sc according to European summary of product characteristics (EU SPC)/prescribed information~* Subjects participating in other clinical studies/trials~* Any female subject of childbearing potential who is not on contraceptives~* Subjects refusal to participate in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Relapsing Multiple Sclerosis (RMS) group (Type: None): Subjects diagnosed with RMS who are prescribed Rebif (Interferon beta-1a)

Based on this trial design, predict the completion outcome and termination type (if applicable).